stockrow
Friday 6 November 2026
Export OMDA’s income statement to Excel — free account
Omada Health, Inc.
OMDA Healthcare Health Information Services
Omada Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $260.2 million, up 53.2% from fiscal 2024.
- Revenue
- +34.2%
- EPS
- +283.3%
- Free cash flow
- +65.8%
Quarter to September 2026, against a year earlier
15.10
3.85
−20.32%
Follow OMDA
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 6 Nov | |
|---|---|---|---|---|---|
|
+7 more TTM periods Free account |
0.00% | 8.38% | 1.84% | 5.72% | |
| (8.37%) | (4.16%) | 1.36% | 4.41% | ||
ROIC |
(97.89%) | (23.37%) | (0.93%) | 14.34% | |
Return on Tangible Assets |
(6.23%) | (3.01%) | 1.88% | 5.63% | |
Average Days of Receivables |
48.51 | 51.52 | 66.66 | 52.82 | |
Free Cash Flow per Share |
0.34 | 0.28 | 0.29 | 0.37 | |
Free Cash Flow |
12.42 | 16.40 | 17.13 | 22.49 | |
Capital Expenditures |
(5.83) | (6.14) | (6.55) | (6.20) | |
| Other line items | |||||
Cash ROIC |
2.75% | 3.68% | 3.61% | 4.36% | |
Accounts Receivable Turnover |
0.00 | 8.94 | 6.89 | 7.43 | |
Accounts Payable Turnover |
0.00 | 15.58 | 10.26 | 14.22 | |
Inventory Turnover |
0.00 | 26.82 | 25.97 | 24.32 | |
Average Days of Payables |
42.02 | 30.94 | 43.72 | 31.35 | |
Days of Inventory on Hand |
18.34 | 14.63 | 15.26 | 18.25 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
15.63% | 15.73% | 15.88% | 16.26% | |
Selling, General and Administrative Expense of Revenue |
54.66% | 53.48% | 52.46% | 0.00% | |
Share Based Compensation of Revenue |
4.98% | 5.05% | 5.53% | 5.84% | |
Interest Coverage |
(4.72) | (5.65) | (1.17) | 22.37 | |
Operating CF/Net income |
(1.43) | (3.58) | 5.50 | 2.04 | |
Depreciation/Fixed assets |
1.15 | 1.11 | 1.06 | 0.00 | |
Capex/Depreciation |
(0.64) | (0.65) | (0.68) | 0.00 | |
Revenue per Share |
7.10 | 4.81 | 5.19 | 5.42 | |
Operating CF per Share |
0.50 | 0.38 | 0.40 | 0.47 | |
Capex per Share |
(0.16) | (0.10) | (0.11) | (0.10) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 |
Columns are period end dates · fundamentals updated 6 Nov 2026